The protein tyrosine kinase inhibitor SU5614 inhibits VEGF-induced endothelial cell sprouting and induces growth arrest and apoptosis by inhibition of c-kit in AML cells (Q44075413)
scientific article
Language:
Current Data About The protein tyrosine kinase inhibitor SU5614 inhibits VEGF-induced endothelial cell sprouting and induces growth arrest and apoptosis by inhibition of c-kit in AML cells
(P31) (Q13442814)
(P248)
(P698) 12135675
(P813) Wednesday, November 29, 2017

(P304) 767-773
(P248)
(P698) 12135675
(P813) Wednesday, November 29, 2017

(P407) (Q1860)
(P887)

(P433) 7
(P248)
(P698) 12135675
(P813) Wednesday, November 29, 2017

(P478) 30
(P248)
(P698) 12135675
(P813) Wednesday, November 29, 2017

(P577) Monday, July 1, 2002
(P248)
(P698) 12135675
(P813) Wednesday, November 29, 2017

(P921) (Q111140)

(Q27159416)
(P248)
(P683) 87159

(P1433) (Q5421109)
(P248)
(P698) 12135675
(P813) Wednesday, November 29, 2017

(P1476) "The protein tyrosine kinase inhibitor SU5614 inhibits VEGF-induced endothelial cell sprouting and induces growth arrest and apoptosis by inhibition of c-kit in AML cells" (language: en)
(P248)
(P698) 12135675
(P813) Wednesday, November 29, 2017

(P2093) Karsten Spiekermann
(P1545) 1
(P248)
(P698) 12135675
(P813) Wednesday, November 29, 2017

Florian Faber
(P1545) 2
(P248)
(P698) 12135675
(P813) Wednesday, November 29, 2017

Robert Voswinckel
(P1545) 3
(P248)
(P698) 12135675
(P813) Wednesday, November 29, 2017

Wolfgang Hiddemann
(P1545) 4
(P248)
(P698) 12135675
(P813) Wednesday, November 29, 2017

(P2860) (Q40377374)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900837-8
(P813) Thursday, January 7, 2021
(P887)

(Q41724143)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900837-8
(P813) Thursday, January 7, 2021
(P887)

(Q28594191)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900837-8
(P813) Thursday, January 7, 2021
(P887)

(Q29615946)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900837-8
(P813) Thursday, January 7, 2021
(P887)

(Q39455739)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900837-8
(P813) Thursday, January 7, 2021
(P887)

(Q61942746)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900837-8
(P813) Thursday, January 7, 2021
(P887)

(Q73942152)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900837-8
(P813) Thursday, January 7, 2021
(P887)

(Q33943905)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900837-8
(P813) Thursday, January 7, 2021
(P887)

(Q37242370)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900837-8
(P813) Thursday, January 7, 2021
(P887)

(Q43648040)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900837-8
(P813) Thursday, January 7, 2021
(P887)

(Q33890319)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900837-8
(P813) Thursday, January 7, 2021
(P887)

(Q40746461)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900837-8
(P813) Thursday, January 7, 2021
(P887)

(Q52968592)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900837-8
(P813) Thursday, January 7, 2021
(P887)

(Q32061790)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900837-8
(P813) Thursday, January 7, 2021
(P887)

(Q41124686)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900837-8
(P813) Thursday, January 7, 2021
(P887)

(Q70957426)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900837-8
(P813) Thursday, January 7, 2021
(P887)

(Q42541293)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900837-8
(P813) Thursday, January 7, 2021
(P887)

(Q33835586)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900837-8
(P813) Thursday, January 7, 2021
(P887)

(Q29618788)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900837-8
(P813) Thursday, January 7, 2021
(P887)

other details